Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

Recruiting Observational Study
Fabry Disease Endothelial Dysfunction Microvasculature
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
63 (estimated)
Sponsor
Technical University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to gain a deeper understanding of endothelial dysfunction in patients with Fabry disease through a prospective study of the retinal microvasculature and to identify an objective, non-invasive marker to assess disease severity and cardiovascular risk in patients. The main questions addressed are: Do dynamic and static retinal vessel analysis parameters differ from those in healthy …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Diagnosis of Fabry disease by genetic testing or GB3 activity in leukocytes. * Signed informed consent form Exclusion Criteria: * Active infection or cancer * Surgery less than 2 weeks prior to inclusion in the study * Known glaucoma * Lack of capacity to g…
Contacts

Christoph Schmaderer, Prof. Dr.

089 4140 5053

christoph.schmaderer@mri.tum.de

CONTACT

Claudia Regenbogen

0894140 5644

claudia.regenbogen@mri.tum.de

CONTACT